2002
DOI: 10.1016/s0022-0248(02)01523-3
|View full text |Cite
|
Sign up to set email alerts
|

Influence of crystal habit on the compression and densification mechanism of ibuprofen

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
15
0
2

Year Published

2007
2007
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(19 citation statements)
references
References 18 publications
1
15
0
2
Order By: Relevance
“…Ibuprofen RDTs had sufficient hardness even when prepared with 88.7 MPa compression pressure. Low melting point (75-77°C) of ibuprofen could be responsible for particle-particle fusion while compressing ibuprofen RDTs, leading to stronger tablets (33,34). The suggested single disintegrant for ibuprofen RDT was CCS (≥4.5% at compression pressure 88.7 MPa) or disintegrant composite combinations for ibuprofen RDTs were SSG-CP (compression pressure range, 88.7-239.4 MPa), MCC-CP (compression pressure range, 88.7-239.4 MPa), MCC-CCS (compression pressure range, 88.7-133 MPa), SSG-CCS (compression pressure range, 88.7-133 MPa) and CP-CCS (compression pressure range, 88.7-239.4 MPa).…”
Section: Formulation Optimizationmentioning
confidence: 99%
“…Ibuprofen RDTs had sufficient hardness even when prepared with 88.7 MPa compression pressure. Low melting point (75-77°C) of ibuprofen could be responsible for particle-particle fusion while compressing ibuprofen RDTs, leading to stronger tablets (33,34). The suggested single disintegrant for ibuprofen RDT was CCS (≥4.5% at compression pressure 88.7 MPa) or disintegrant composite combinations for ibuprofen RDTs were SSG-CP (compression pressure range, 88.7-239.4 MPa), MCC-CP (compression pressure range, 88.7-239.4 MPa), MCC-CCS (compression pressure range, 88.7-133 MPa), SSG-CCS (compression pressure range, 88.7-133 MPa) and CP-CCS (compression pressure range, 88.7-239.4 MPa).…”
Section: Formulation Optimizationmentioning
confidence: 99%
“…Crystallization can therefore prove to be a very important tool in modifying the external structure of a crystal drug for the production of a particular dosage form (i.e. suspensions [4] or tablets [5][6][7]). Since during crystallization a great number of variables (i.e.…”
Section: Introductionmentioning
confidence: 99%
“…By increasing the confidence and reducing uncertainty in the drug-related parameters affecting dissolution rate via separately modeling experimental pH-solubility profile, one may redirect an available semimechanistic dissolution model, such as the DLM, to work in an estimation mode and unveil formulationrelated factors controlling dissolution kinetics. In this context, the P-PSD for formulations containing plastic-elastic drugs such as ibuprofen 22,25 is based on the effective surface area concept, which is a geometrical controlling factor for a chemical reaction involving fine particulate materials. 26 Even though not an ideal physiologically and mechanistically based biopharmaceutics modeling approach, 27 the semimechanistic IVIVE approach still allows one to leverage experimentally obtained particle size distributions for plastic-elastic materials (e.g., starting values for P-PSD modeling) to investigate the interplay between drug-, formulation-, and GIrelated properties and ultimately to derive individual intraluminal dissolution profiles, which are essential to inform IVIVCs and virtual bioequivalence trials.…”
Section: Discussionmentioning
confidence: 99%